BIO-PATH HOLDINGS INC (BPTH) Stock Analyst Earnings Estimates
NASDAQ:BPTH - Nasdaq - US09057N4097 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13K | 37K 184.62% | N/A -100.00% | 56.911M | 86.602M 52.17% | 117.53M 35.71% | 132.9M 13.08% | |||||||||||
| EBITDA YoY % growth | -5.283M -20.85% | -8.271M -56.56% | -8.555M -3.43% | N/A 11.68% | N/A -13.27% | N/A -26.60% | N/A 4.33% | N/A -33.24% | N/A -14.10% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.485M -20.74% | -8.475M -54.53% | -8.966M -5.79% | N/A 10.97% | -8.726M -8.91% | -11.788M -25.48% | -8.784M 4.26% | -13.79M -33.11% | -16.441M -13.97% | -12.261M 22.61% | -11.528M 5.98% | -11.754M -1.96% | -11.986M -1.97% | 44.687M 472.83% | 74.136M 65.90% | 104.82M 41.39% | 119.92M 14.41% | |
| Operating Margin | N/A | -65,192.31% | -24,232.43% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 78.52% | 85.61% | 89.19% | 90.23% | |
| EPS YoY % growth | -280.00 -71.57% | -360.00 -28.57% | N/A | N/A | -64.67 | -62.02 12.79% | -26.11 44.33% | -37.33 -21.02% | -34.07 1.97% | -3.23 91.32% | -1.58 51.10% | -1.51 4.52% | -1.47 2.70% | 1.73 218.06% | 2.83 62.94% | 3.34 18.05% | 3.49 4.59% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 94.65% | -0.39 92.06% | -0.39 66.59% | -0.40 43.17% | -0.41 -8.11% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.707M 10.75% | -2.774M 24.91% | -2.845M 6.36% | -2.917M -10.75% | -2.992M -10.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.70 89.06% | -1.04 | 0.34 | 32.72% |
| Q2 2024 Q2Q % growth | -1.16 89.06% | -1.57 | 0.41 | 26.15% |
| Q1 2024 Q2Q % growth | -4.88 63.03% | -4.63 | -0.25 | -5.38% |
| Q4 2023 Q2Q % growth | -7.05 32.21% | -5.51 | -1.54 | -28.00% |
| Q3 2023 Q2Q % growth | -6.40 34.69% | -6.94 | 0.54 | 7.73% |
| Q2 2023 Q2Q % growth | -10.60 -26.19% | -10.61 | 0.01 | 0.08% |
| Q1 2023 Q2Q % growth | -13.20 -40.43% | -9.18 | -4.02 | -43.79% |
| Q4 2022 Q2Q % growth | -10.40 11.86% | -9.18 | -1.22 | -13.29% |
| Q3 2022 Q2Q % growth | -9.80 -68.97% | -9.28 | -0.52 | -5.58% |
| Q2 2022 Q2Q % growth | -8.40 -61.54% | -10.10 | 1.70 | 16.82% |
| Q1 2022 Q2Q % growth | -9.40 -9.30% | -9.28 | -0.12 | -1.27% |
| Q4 2021 Q2Q % growth | -11.80 -3.51% | -6.53 | -5.27 | -80.76% |
| Q3 2021 Q2Q % growth | -5.80 63.75% | -6.73 | 0.93 | 13.84% |
| Q2 2021 Q2Q % growth | -5.20 52.73% | -8.06 | 2.86 | 35.47% |
| Q1 2021 Q2Q % growth | -8.60 52.22% | -10.10 | 1.50 | 14.83% |
| Q4 2020 Q2Q % growth | -11.40 21.92% | -15.91 | 4.51 | 28.36% |
| Q3 2020 Q2Q % growth | -16.00 -2.56% | -16.93 | 0.93 | 5.50% |
| Q2 2020 Q2Q % growth | -11.00 36.78% | -18.16 | 7.16 | 39.41% |
| Q1 2020 Q2Q % growth | -18.00 | -13.67 | -4.33 | -31.69% |
| Q4 2019 Q2Q % growth | -14.60 | -14.08 | -0.52 | -3.72% |
| Q3 2019 Q2Q % growth | -15.60 | -15.10 | -0.50 | -3.34% |
| Q2 2019 Q2Q % growth | -17.40 | -12.24 | -5.16 | -42.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 92.37% | 0% | 48.87% |
| Revenue | N/A | N/A | N/A | N/A |